Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
Titel:
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
Auteur:
Gianni, Luca Pienkowski, Tadeusz Im, Young-Hyuck Roman, Laslo Tseng, Ling-Ming Liu, Mei-Ching Lluch, Ana Staroslawska, Elżbieta de la Haba-Rodriguez, Juan Im, Seock-Ah Pedrini, Jose Luiz Poirier, Brigitte Morandi, Paolo Semiglazov, Vladimir Srimuninnimit, Vichien Bianchi, Giulia Szado, Tania Ratnayake, Jayantha Ross, Graham Valagussa, Pinuccia